RESUMO
This study aimed to assess the prevalence and clinical and psychosocial correlates of psychiatric symptoms in a sample of HIV patients in the Gambia. Data from 44 HIV-positive outpatients were collected at a Genito-Urinary Medicine clinic in Fajara, the Gambia. Translated versions of the Impact of Event Scale Revised and the Centre for Epidemiologic Studies Short Depression Scale were used to assess posttraumatic stress disorder (PTSD) symptoms and depressive symptoms, respectively. The Pictorial Representation of Illness and Self Measure revised was used to assess illness perception (IP). All other data (e.g., CD4 counts) were retrieved from medical charts or through standardised questions. The prevalence of PTSD symptoms (43.2%) and depressive symptoms (40.9%) was high. Not having an independent income and having a CD4 count under 200 cells/µl were independent correlates of depressive symptoms. Only IP was an independent correlate of PTSD symptoms. Finally, IP tended to moderate the relationship between CD4 cell counts and depressive symptoms. These findings indicate that routine screening for psychiatric symptoms is both necessary and feasible among HIV patients in the Gambia. In addition, any intervention targeting these symptoms should take IP into account.
Assuntos
Transtorno Depressivo/psicologia , Infecções por HIV/psicologia , Transtornos de Estresse Pós-Traumáticos/psicologia , Adolescente , Adulto , Contagem de Linfócito CD4 , Transtorno Depressivo/epidemiologia , Feminino , Gâmbia/epidemiologia , Soropositividade para HIV , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Autoavaliação (Psicologia) , Fatores Socioeconômicos , Transtornos de Estresse Pós-Traumáticos/epidemiologia , Adulto JovemRESUMO
Shigella toxin-producing Escherichia coli (STEC) is well known for its complications such as haemolytic uraemic syndrome (HUS), but neurological symptoms have also been reported. While most cases of infection with STEC occur with concurrent HUS, we describe a patient with severe neurological symptoms in the absence of HUS. LEARNING POINTS: Shigella toxin producing Escherichia coli (STEC) are bacteria that cause haemorrhagic colitis.Generally, infections with STEC occur with a concurrent haemolytic uraemic syndrome (HUS).However, infections with STEC can occur with neurological symptoms without HUS.
RESUMO
Buruli ulcer (BU) is a tropical, infectious skin disease. The resulting ulcer can take a long time to heal, and a high standard of wound care is essential. Currently, the only dressing used for BU wound care is gauze, and its removal causes pain and bleeding. We performed a pilot implementation project using HydroTac(®) (HARTMANN, Heidenheim, Germany), a modern dressing combining foam with a hydrogel component. For future BU treatment, we recommend to use a more absorbent dressing than the HydroTac dressing used in the current project. However, we show that modern dressings can be applied to BUs and that HydroTac dressings yield clean, healing wounds, and prevent the pain and bleeding associated with gauze dressings. Wound care is a vital but to date neglected aspect of BU management.
Assuntos
Bandagens , Úlcera de Buruli/terapia , Cicatrização , Adolescente , Úlcera de Buruli/microbiologia , Criança , Gana , Humanos , Hidrogéis/química , Projetos PilotoRESUMO
Buruli ulcer (BU) is a disease affecting the skin, subcutaneous fat, and bone tissues. Wound care is important in the prevention of disabilities. Awareness of current wound care practices in BU-endemic regions is necessary for future wound care interventions. Thirty-one health care workers in Ghana and Benin were interviewed with a semi-structured interview, complemented by structural observations. Quantitative data were analyzed through t tests and one-way analysis of variance, and qualitative data through descriptive statistics. There appeared to be a general understanding of wound assessment. A large variety of different topical antiseptics was reported to be used, pressure irrigation was never reported. Gauze was the main dressing type and a moist environment was preferred, but could not be maintained. Bleeding and pain were observed frequently. Standard of wound care differed importantly between health care personnel and between institutions and adherence to World Health Organization guidelines was low.
Assuntos
Anti-Infecciosos Locais/uso terapêutico , Úlcera de Buruli/terapia , Fidelidade a Diretrizes/normas , Mycobacterium ulcerans , Infecção dos Ferimentos/terapia , Bandagens , Benin , Úlcera de Buruli/microbiologia , Úlcera de Buruli/cirurgia , Feminino , Gana , Humanos , Masculino , Doenças Negligenciadas , Pele/efeitos dos fármacos , Pele/microbiologia , Padrão de Cuidado , Organização Mundial da Saúde , Infecção dos Ferimentos/microbiologia , Infecção dos Ferimentos/cirurgiaRESUMO
BACKGROUND: Buruli Ulcer is a tropical skin disease caused by Mycobacterium ulcerans, which, due to scarring and contractures can lead to stigma and functional limitations. However, recent advances in treatment, combined with increased public health efforts have the potential to significantly improve disease outcome. OBJECTIVES: To study the Quality of Life (QoL) of former Buruli Ulcer patients who, in the context of a randomized controlled trial, reported early with small lesions (cross-sectional diameter <10 cm), and received a full course of antibiotic treatment. METHODS: 127 Participants of the BURULICO drug trial in Ghana were revisited. All former patients aged 16 or older completed the Dermatology Life Quality Index (DLQI) and the abbreviated World Health Organization Quality of Life scale (WHOQOL-BREF). The WHOQOL-BREF was also administered to 82 matched healthy controls. Those younger than 16 completed the Childrens' Dermatology Life Quality Index (CDLQI) only. RESULTS: The median (Inter Quartile Range) score on the DLQI was 0 (0-4), indicating good QoL. 85% of former patients indicated no effect, or only a small effect of the disease on their current life. Former patients also indicated good QoL on the physical and psychological domains of the WHOQOL-BREF, and scored significantly higher than healthy controls on these domains. There was a weak correlation between the DLQI and scar size (ρ = 0.32; p<0.001). CONCLUSIONS: BU patients who report early with small lesions and receive 8 weeks of antimicrobial therapy have a good QoL at long-term follow-up. These findings contrast with the debilitating sequelae often reported in BU, and highlight the importance of early case detection.